Safety of administration of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, before curative-intent treatment in patients with HPV16+ oropharyngeal squamous cell carcinoma.

Authors: Sidharth Puram, Peter John Oppelt, Jessica C. Ley, Jesse M. Zaretsky, Ryan Jackson, Patrik Pipkorn, Richard A. Harbison, Jason Rich, Wade Thorstad, Nikhil Rammohan, Jennifer F. De Los Santos, Michael James Moravan, Anthony J. Apicelli, Jingxia Liu, Michael Atteberry, Ashley Short, Steven N. Quayle, Matteo Levisetti, Anish Suri, Douglas Adkins

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18086

Source: Full article

---

Abstract

e18086